| Identification | Back Directory | [Name]
AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) | [CAS]
148914-08-3 | [Synonyms]
Amyloid β/A4 Protein Precursor (403-407)
AMyloid b/A4 Protein Precursor770 (403-407)
Amyloid β/A4 Protein Precursor??? (403-407)
L-Serine, L-arginyl-L-α-glutamyl-L-arginyl-L-methionyl-
Amyloid β/A4 Protein Precursor770 (403-407), APP770 (403-407)
Amyloid beta/A4 Protein Precursor770 (403-407) trifluoroacetate salt
Amyloid β/A4 Protein Precursor??? (403-407) trifluoroacetate salt/APP??? (403-407), β-Amyloid / A4 Protein Precursor (APP) (328-332) | [Molecular Formula]
C25H47N11O9S | [MDL Number]
MFCD18782119 | [MOL File]
148914-08-3.mol | [Molecular Weight]
677.78 |
| Hazard Information | Back Directory | [Uses]
RERMS are bioactive peptides produced from the active regions of amyloid-β and A4 protein precursors that promote fibroblast growth and can be used in the study of neurodegenerative diseases[1]. | [References]
[1] Ninomiya, et al. "Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth." The Journal of cell biology 121.4 (1993): 879-886. DOI:10.1083/jcb.121.4.879 |
|
|